Melanoma laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:  Yazan Daaboul, M.D.; Serge Korjian M.D.

Melanoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Melanoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Genetic Counselling

Cost-Effectiveness of Therapy

Future or Investigational Therapies

2019 AAD Guidelines for management of Primary Cutaneous Melanoma (CM)

Guidelines for Diagnosis of Primary CM

Guidelines for Treatment of Primary CM

Guidelines for management of Primary CM in Pregnancy

Case Studies

Case #1

Melanoma laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Melanoma laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Melanoma laboratory tests

CDC on Melanoma laboratory tests

Melanoma laboratory tests in the news

Blogs on Melanoma laboratory tests

Directions to Hospitals Treating Melanoma

Risk calculators and risk factors for Melanoma laboratory tests

## Overview[edit | edit source]

There are no laboratory findings associated with the diagnosis of melanoma. Serum lactate dehydrogenase (LDH) may be elevated among patients with metastasis.

## Laboratory Findings[edit | edit source]

* There are no laboratory findings associated with the diagnosis of melanoma. Measurement of serum LDH may be considered for follow-up among patients who have been diagnosed with stage IB-IV melanoma.[1]

### Lactate Dehydrogenase (LDH)[edit | edit source]

* Once metastatic melanoma is diagnosed, serum lactate dehydrogenase (LDH) may be helpful for follow-up.[1]
* For patients with stage IB-IV melanoma, measurement of serum LDH may be considered every 6-12 months.[1]

## References[edit | edit source]

1. ↑ 1.0 1.1 1.2 Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A; et al. (2013). "Melanoma, version 2.2013: featured updates to the NCCN guidelines". J Natl Compr Canc Netw. 11 (4): 395–407. PMID 23584343.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)